MEDULLARY SEROTONERGIC SYSTEM AND RESPIRATORY CONTROL IN THE UNANESTHETIZED PIG
未麻醉猪的髓质血清素系统和呼吸控制
基本信息
- 批准号:7410020
- 负责人:
- 金额:$ 26.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAll SitesAnatomyAntibodiesApneaAsphyxiaAutoreceptorsBindingBlood PressureBrain StemBreathingCarbon DioxideCarrier ProteinsCellsChemicalsDevelopmentDialysis procedureDisruptionEventFamily suidaeGoalsHypoxiaImmunohistochemistryInfantInjection of therapeutic agentLateralLifeLocalizedLocationMicrodialysisModelingMuscarinic Acetylcholine ReceptorMuscarinic M1 ReceptorMuscarinicsNeuronsNewborn InfantNuclearPathogenesisPeptidesPhenotypePhysical DialysisProcessProductionReflex actionReflex controlRoleSerotoninSerotonin AgonistsSideSiteSleepStanoloneSubstance PSubstance P ReceptorSudden DeathSudden infant death syndromeSus scrofaSystemTestingThyroid GlandThyrotropin-Releasing HormoneTissuesToxinTriiodothyronineWakefulnessbaseinhibitor/antagonistinterestkillingsm1-toxin1medullary serotonergic systemnoradrenergicreceptorresearch studyrespiratoryresponseserotonin receptorserotonin transportersubstance P-saporintelenzepinethermal stress
项目摘要
Based on observations made in brainstem tissue of SIDS cases we hypothesize that the pathogenesis of SIDS involves abnormalities in what we now call the 'medullary serotonergic system'. In this project we define in newborn piglets the neuroehemical and receptor anatomy of the neurons in the medullary serotonergic system, we specifically disrupt them focally or widely, and we observe the resultant effects on an army of homeostatic processes. These include the ventilatory responses to increased CO2 and decreased O2, upper airway reflexes, and
blood pressure effects on breathing. We use an unanesthetized newborn piglet model in which we can easily test this array of homeostatic processes in both wakefulness and sleep. Initially we inhibit serotoncrgic neurons by microdialysis of an agonist for the 5-HT(1A) autorceeptor or kill them by injection of 5, 7 DHT or a conjugate of anantibody for the serotonin transport protein (SERT) and the cell toxin saporin (SAP). We will also inhibit and kill neurons within the medullary serotonergic system that express the NK1 or muscarinic M1 subtype receptors. For neurons with NK1 receptors we use an NK1 antagonist or substance P-SAP. For neurons with M1 receptors we use telenzepine or the m1-toxin1 (a highly specific long acting M1 receptor antagonist). These experiments will involve focal application at various sites within three rostral-to-caudal colulumns that define the medullary serotonergic system or widely at 'all' sites simultaneously. With focal application we ask if each homeostatic process can be localized to a specific site within the medullary serotonergic system. With wide application we ask if these homeostatic processes utilize neurons distributed at many locations. Serotonergic neurons within the meduliary serotonergic system can be further classified by peptides that are co-localized within them. Thyrotropin releasing hormone (TRH) and substance P (SP) are two such that are of particular interest in that they have known strong effects on breathing and blood pressure. We will microdialyze T3 in the medullary raphe, which will bind to nuclear beta2 thyroid receptors and inhibit TRH production and release allowing us to examine the role of
endogenous TRH in the function of our array of homeostatic processes. Overall, the goal of this project is to see if a induced focal or widely distributed abnormality in the medullary semtonergic system couid affect function in our array of homeostatic processes such as to contribute to sudden death.
根据对小儿麻痹症患者脑干组织的观察,我们推测小儿麻痹症的发病机制涉及我们现在所说的“延髓5-羟色胺能系统”的异常。在这个项目中,我们定义了新生仔猪延髓5-羟色胺能系统中神经元的神经化学和受体解剖,我们特定地局部或广泛地干扰它们,并观察其对一系列体内平衡过程的结果。这些包括对二氧化碳增加和氧气减少的呼吸反应,上呼吸道反射,以及
血压对呼吸有影响。我们使用了一个未麻醉的新生小猪模型,在这个模型中,我们可以很容易地在清醒和睡眠中测试这一系列的动态平衡过程。最初,我们通过微透析5-羟色胺(1A)受体激动剂或注射5,7-二羟色胺或5-羟色胺转运蛋白(SERT)和细胞毒素皂苷(SAP)抗体的结合物来抑制5-羟色胺能神经元。我们还将抑制和杀死延髓5-羟色胺能系统中表达NK1或M_1亚型受体的神经元。对于有NK1受体的神经元,我们使用NK1拮抗剂或P-SAP物质。对于有M1受体的神经元,我们使用替伦西平或M1毒素1(一种高度特异的长效M1受体拮抗剂)。这些实验将涉及在定义延髓5-羟色胺能系统的三个嘴端到尾端的柱体内的不同部位集中应用,或者广泛地同时在所有部位应用。在局部应用的情况下,我们询问每个内稳态过程是否可以定位于延髓5-羟色胺能系统中的特定部位。随着广泛的应用,我们问这些动态平衡过程是否利用了分布在许多位置的神经元。延髓5-羟色胺能系统内的5-羟色胺能神经元可以通过共同定位在其中的多肽进一步分类。促甲状腺激素释放激素(TRH)和P物质(SP)是两种特别令人感兴趣的物质,因为它们对呼吸和血压有很强的影响。我们将微透析延髓缝中的T3,它将与核β2甲状腺受体结合,并抑制TRH的产生和释放,从而使我们能够检查
内源性TRH在我们的一系列动态平衡过程中的作用。总体而言,这个项目的目标是看看延髓语义能系统中诱发的局灶性或广泛分布的异常是否会影响我们的一系列体内平衡过程的功能,例如导致猝死。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EUGENE Edward NATTIE其他文献
EUGENE Edward NATTIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EUGENE Edward NATTIE', 18)}}的其他基金
VENTRAL MEDULLA, BREATHING, AND CENTRAL CHEMORECEPTION
腹延髓、呼吸和中枢化学感受器
- 批准号:
6581880 - 财政年份:2002
- 资助金额:
$ 26.79万 - 项目类别:
VENTRAL MEDULLA, BREATHING, AND CENTRAL CHEMORECEPTION
腹延髓、呼吸和中枢化学感受器
- 批准号:
6430009 - 财政年份:2001
- 资助金额:
$ 26.79万 - 项目类别:
VENTRAL MEDULLA, BREATHING, AND CENTRAL CHEMORECEPTION
腹延髓、呼吸和中枢化学感受器
- 批准号:
6302061 - 财政年份:2000
- 资助金额:
$ 26.79万 - 项目类别:
VENTRAL MEDULLA, BREATHING, AND CENTRAL CHEMORECEPTION
腹延髓、呼吸和中枢化学感受器
- 批准号:
6108929 - 财政年份:1999
- 资助金额:
$ 26.79万 - 项目类别:
VENTRAL MEDULLA, BREATHING, AND CENTRAL CHEMORECEPTION
腹延髓、呼吸和中枢化学感受器
- 批准号:
6272450 - 财政年份:1998
- 资助金额:
$ 26.79万 - 项目类别:
CSF and the central chemical control of breathing.
CSF 和呼吸的中枢化学控制。
- 批准号:
8010857 - 财政年份:1994
- 资助金额:
$ 26.79万 - 项目类别:
CSF and the central chemical control of breathing.
CSF 和呼吸的中枢化学控制。
- 批准号:
8211022 - 财政年份:1994
- 资助金额:
$ 26.79万 - 项目类别:
CSF AND THE CENTRAL CHEMICAL CONTROL OF BREATHING
CSF 和呼吸的中枢化学控制
- 批准号:
7213327 - 财政年份:1994
- 资助金额:
$ 26.79万 - 项目类别:
CSF AND THE CENTRAL CHEMICAL CONTROL OF BREATHING
CSF 和呼吸的中枢化学控制
- 批准号:
6896919 - 财政年份:1994
- 资助金额:
$ 26.79万 - 项目类别:
CSF AND THE CENTRAL CHEMICAL CONTROL OF BREATHING
CSF 和呼吸的中枢化学控制
- 批准号:
6695165 - 财政年份:1994
- 资助金额:
$ 26.79万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 26.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 26.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 26.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




